IP Library Patent Application 14886946
Patent Application
App. No. 14/886,946

UMBILICAL CORD PRODUCTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/886,946
Abstract

Disclosed herein, in certain instances, are tissue grafts derived from UCAM. Further disclosed herein, in certain instances, are use for tissue grafts derived from UCAM.

Claims (20)

1 . A method of treating a wound in an individual in need thereof, comprising: contacting a wound of the individual with an umbilical cord powder, or with an umbilical cord product from which water has not been removed.

2 . The method of claim 1 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is derived from frozen or previously-frozen umbilical cord.

3 . The method of claim 1 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed comprises amniotic membrane and Wharton's jelly.

4 . The method of claim 1 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed consists essentially of umbilical cord-derived amniotic membrane.

5 . The method of claim 1 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is substantially free of a vein or artery.

6 . The method of claim 1 , wherein the wound is an ulcer.

7 . The method of claim 6 , wherein the ulcer is a foot ulcer, a diabetic foot ulcer, an arterial insufficiency ulcer, a venous stasis (VS) ulcer, or an ocular ulcer.

8 . The method of claim 1 , wherein the wound is a burn, a laceration, an incision, an abrasion, a puncture, a penetration, necrosis, or damage to an eye.

9 . The method of claim 2 , wherein the umbilical cord product from which water has not been removed is a substantially-flattened sheet or tubular sheet, or is pulverized.

10 . The method of claim 1 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is cryopreserved, terminally sterilized, or a combination thereof.

11 . A method for reducing inflammation, scarring, or adhesion in a tissue in need thereof, comprising: contacting the tissue with an umbilical cord powder, or with an umbilical cord product from which water has not been removed.

12 . The method of claim 11 , wherein the contacting occurs in vivo.

13 . The method of claim 11 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is derived from frozen or previously-frozen umbilical cord.

14 . The method of claim 11 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed comprises amniotic membrane and Wharton's jelly.

15 . The method of claim 11 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed consists essentially of amniotic membrane.

16 . The method of claim 11 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is substantially free of vein or artery.

17 . The method of claim 11 , wherein the umbilical cord powder or the umbilical cord product from which water has not been removed is cryopreserved, terminally sterilized, or a combination thereof.

18 . The method of claim 11 , wherein the tissue comprises an ulcer, a burn, a laceration, an incision, an abrasion, a puncture, a penetration, necrosis, or damage an eye.

19 . The method of claim 18 , wherein the ulcer is a foot ulcer, a diabetic foot ulcer, an arterial insufficiency ulcer, a venous stasis (VS) ulcer, or an ocular ulcer.

20 . The method of claim 11 , wherein the umbilical cord product from which water has not been removed is a substantially-flattened sheet or tubular sheet, or is pulverized.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FINANCIAL TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0165 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2024
From: MIDCAP FUNDING IV TRUST
To: BIOTISSUE HOLDINGS INC. (F/K/A TISSUE TECH, INC.); BIOTISSUE OCULAR INC. (F/K/A BIO-TISSUE, INC.); BIOTISSUE SURGICAL INC. (F/K/A AMNIOX MEDICAL, INC.)
Reel/Frame 067666/0200 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - TERM LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060116/0413 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - REVOLVING LOAN Recorded May 18, 2022
From: TISSUETECH, INC.; BIO-TISSUE, INC.; AMNIOX MEDICAL, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 060116/0468 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2015
From: TSENG, SCHEFFER; TAN, EK KIA; TSENG, AMY
To: TISSUETECH, INC.
Reel/Frame 036825/0087 →